Atreca, Inc.
United States of America (USA)
1 August 2019 - 31 July 2020
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Atreca, Inc. published between 1 August 2019 - 31 July 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| Count | Share |
|---|---|
| 1 | 0.31 |
Outputs by subject (Share)
| Subject | Count | Share | |
|---|---|---|---|
| Life Sciences | 1 | 0.31 | |
| Chemistry | 1 | 0.31 | |
Top articles by Altmetric score in current window
Potent antibody lineage against malaria transmission elicited by human vaccination with Pfs25
Nature Communications
2019-09-24
1 August 2019 - 31 July 2020
International vs. domestic collaboration by Share
- 63.41% Domestic
- 36.59% International
Note: Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators by Share (4 total)
- Atreca, Inc., United States of America (USA)
- Domestic institution
Top 10 international collaborators by Share (2 total)
- Atreca, Inc., United States of America (USA)
- Foreign institution
Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.
Affiliated joint institutions and consortia
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
